Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: J Mol Cell Cardiol. 2012 May 17;53(2):259–267. doi: 10.1016/j.yjmcc.2012.05.005

Fig 2. Effect of AdV-ATF6 on PDIA6 expression.

Fig 2

Panel A- NRVMCs were infected with AdV-Con or AdV-ATF6. Twenty-four hours later, cultures were analyzed for ATF6 and GAPDH mRNAs. Values are mean ATF6/GAPDH mRNA ± SE, n=3 cultures per treatment.

Panel B- NRVMCs were infected with AdV-Con or AdV-ATF6. Forty-eight hours later, culture extracts were analyzed for PDIA6 and GAPDH mRNA. Values are mean PDIA6/GAPDH mRNA ± SE, n=3 cultures per treatment.

Panel C- NRVMCs were treated as described for Panel A, except extracts were analyzed for PDIA6 and GAPDH protein by immunoblotting. Relative blot intensities of PDIA6/GAPDH expressed as fold of control (bottom). Values are mean relative PDIA6/GAPDH ± SE, n=3 cultures per treatment.